A detailed analysis of survival time for the three main diagnoses (lung, colorectal, and pancreatic cancer) showed that in patients with lung cancer, the covariates “CRP value,” “days from first diagnosis to randomization,” and “gender” were significantly associated with survival time. The gene discussed is CRP; the disease is familial pancreatic carcinoma.